A Multicenter Non-interventional Study to Observe the Safety and Efficacy of Etanercept (Enbrel) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 15 Feb 2017 Status changed from recruiting to completed.
- 30 Jun 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 30 Jun 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.